We’re revisiting an old friend today. This one has been quietly compounding in the background, consistently defying competition and getting re-rated upwards and onwards.
We are looking at a business trading at a massive 15.4% 2026 Free Cash Flow yield, printing 25% EBIT margins, and on the verge of 10-bagging its revenue since inception (2017).
Numbers like this usually come with a catch… but here, the only catch is that you haven’t looked at it yet.
⭐ Overall grade: 9.5 / 10
Pick of the Week. A curated series of high-conviction research on companies currently under our microscope. We screen for specific dislocations where the market has mispriced the balance sheet or earnings power.
The Selection Criteria:
Asset Arbitrage: Trading at a discount to tangible liquidation value.
Backlog Disconnect: Future contracted revenue ignored by the market.
Hidden Margins: Structural profitability masked by temporary noise or CAPEX cycles.
The Structure:
The Business: A concise operational overview.
The Dislocation: The specific structural reason the opportunity exists.
The Valuation: A stress-tested snapshot including downside risks (”Red Flags”) and our proprietary score.
None of the following should be construed as investment advice. Please consult a financial advisor before making any investment decision. You will find a full disclaimer at the end of this post.
🏰 LIMES Schloss Clinics ($LIK)
Headquartered in Cologne and listed in the “German Nasdaq”, LIMES Schlosskliniken operates a network of super premium private clinics for psychiatry, psychotherapy, and psychosomatics.